Firestone Capital Management’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Firestone Capital Management’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-74	Closed	-$6K	–	478
2021 Q3	$6K	Hold	74	–	–	﹤0.01%	408
2021 Q2	$6K	Hold	74	–	–	﹤0.01%	399
2021 Q1	$5K	Hold	74	–	–	﹤0.01%	416
2020 Q4	$3K	Hold	74	–	–	﹤0.01%	424
2020 Q3	$4K	Hold	74	–	–	﹤0.01%	374
2020 Q2	$3K	Hold	74	–	–	﹤0.01%	398
2020 Q1	$2K	Hold	74	–	–	﹤0.01%	416
2019 Q4	$4K	Buy	+74	New	+$3.59K	﹤0.01%	402

Other funds holding DMK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Firestone Capital Management's DMK Position: Q4 2021 in Review

Firestone Capital Management sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q4 2021, closing a stake of 74 shares — an estimated $6K sold.

Firestone Capital Management first reported a position in DMK in Q4 2019 and held it in 8 quarters. The position peaked at $6K in Q3 2021. 49 funds tracked by Wall St. Rank hold DMK as of Q4 2021.

Firestone Capital Management reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q4 2021 after selling out during the quarter.
Firestone Capital Management sold 74 DMK Pharmaceuticals Corporation Common Stock shares in Q4 2021, an estimated $6K.
Firestone Capital Management first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2019 and held it in 8 quarters.
Firestone Capital Management's DMK Pharmaceuticals Corporation Common Stock position peaked at $6K in Q3 2021.
49 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q4 2021.

Based on Firestone Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.